| Open | 47.48 |
| LTP | 46.46 |
| Previous Close | 46.54 |
| Day High | 48.8 |
| Day Low | 46.18 |
| Volume | 5087 |
| Code : | LYKISLTD |
| Name : | Lykis Limited |
| Country : | India |
| Sector : | |
| Industry: | Household & Personal Products |
| Market CAP : | 91 Cr |
| Stock P/E: | 38.21 |
| ROCE: | 7.47% |
| Book Value: | 17.02 |
| Dividend Yield : | 0% |
| Most Recent Quarter : | 2024-06-30 |
| Revenue/Sales TTM : | 370 Cr |
| Operating Margin TTM : | 0.0191% |
| Return On Equity TTM : | 0.07% |
| Profit Margin : | 0.01% |
| Market Capitalization : | 91 Cr |
| EBITDA : | 5 Cr |
| Book Value : | 17.02 |
| PERatio : | 38.21 |
| Dividend Share : | |
| Earnings Share : | 1.23 |
| Gross Profit TTM : | 49 Cr |
| Quarterly Earnings Growth YOY : | -0.55% |
| Dividend Yield : | % |
| Quarterly Revenue GrowthYOY : | -0.15 |
| Diluted Eps TTM : | 1.23 |
| Trailing PE : | 38.21 |
| Price Sales TTM : | 0.25 |
| Enter Prise Value : | 166 Cr |
| Enter Prise Value Ebidta : | 17.7268 |
| Forward PE : | 0 |
| Price Book MRQ : | 2.74 |
| Enter Prise Value Revenue : | 0.45 |
| Forward Annual Dividend Rate : | 0 |
| Payout Ratio : | 0 |
| Ex Dividend Date : | |
| Last Split Date : | 0000-00-00 |
| Forward Annual Dividend Yield : | 0 |
| Dividend Date : | |
| Last Split Factor : |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 48.11 | 49.77 | 50.73 | 47.15 | 45.49 | 44.53 | 42.87 |
| Fibonacci | 48.28 | 49.85 | 50.9 | 47.23 | 45.66 | 44.61 | 43.04 |
| Camarilla | 47.77 | 49.6 | 50.39 | 46.98 | 45.15 | 44.36 | 42.53 |
| Classic | 48.79 | 50.11 | 51.41 | 47.49 | 46.17 | 44.87 | 43.55 |
| Days 50 Day MA |
47.62 |
| Days 200 Day MA |
47.62 |
| Days 52 Week High |
82.62 |
| Days 52 Week Low |
39.5 |
| Quarterly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | EBIT | NetInterest Income | Income Tax Expense |
| Jun 2024 | 73 Cr | 71 Cr | 82 Lac | 0 | 2 Cr | 0 | 0 | -2 Cr | 0 |
| Mar 2024 | 111 Cr | 112 Cr | -1 Cr | 0 | 51 Lac | -6 Lac | 0 | -1 Cr | 0 |
| Dec 2023 | 93 Cr | 91 Cr | 1 Cr | 0 | 1 Cr | 0 | 0 | -1 Cr | 0 |
| Sep 2023 | 99 Cr | 96 Cr | 2 Cr | 0 | 2 Cr | 0 Cr | 0 | -2 Cr | 0 |
| Yearly | Sale | Expense | Net Income | Other Operating Expenses | Interest Expense | Tax Provision | Interest Income | Net Interest Income | Income Tax Expense |
| Mar 2024 | 395 Cr | 387 Cr | 4 Cr | 0 | 7 Cr | 0 Cr | 12 Lac | -7 Cr | 0 |
| Mar 2023 | 446 Cr | 421 Cr | 16 Cr | 0 | 6 Cr | 4 Cr | 3 Lac | -7 Cr | 0 |
| Mar 2022 | 323 Cr | 322 Cr | 2 Cr | 0 | 3 Cr | 0 Cr | 93 k | -3 Cr | 0 |
| Mar 2021 | 57 Cr | 59 Cr | -7 Cr | 0 | 2 Cr | -3 Cr | 27 Lac | -2 Cr | 0 |
| Quarterly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Mar 2024 | 141 Cr | 133 Cr | 10 Cr | 110 Cr | 0 | 106 Cr | 31 Cr |
| Sep 2023 | 159 Cr | 153 Cr | 27 Cr | 128 Cr | 0 | 23 Cr | 31 Cr |
| Mar 2023 | 185 Cr | 178 Cr | 16 Cr | 157 Cr | 0 | 153 Cr | 28 Cr |
| Sep 2022 | 178 Cr | 169 Cr | 18 Cr | 162 Cr | 0 | 157 Cr | 16 Cr |
| Yearly | Total Assets | Total Current Assets | Inventory | Total Liab | Other Liab | Total Current Liabilities | Total Stock holder Equity |
| Mar 2024 | 141 Cr | 133 Cr | 10 Cr | 110 Cr | 0 | 106 Cr | 31 Cr |
| Mar 2023 | 185 Cr | 178 Cr | 16 Cr | 157 Cr | 0 | 153 Cr | 28 Cr |
| Mar 2022 | 135 Cr | 127 Cr | 14 Cr | 123 Cr | 0 | 120 Cr | 12 Cr |
| Mar 2021 | 88 Cr | 82 Cr | 13 Cr | 78 Cr | 0 | 75 Cr | 10 Cr |
| Quarterly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Jun 2024 | 0 | 0 | 0 | 0 | 82 Lac | 0 | 0 |
| Mar 2024 | 0 | 0 | 0 | 0 | -1 Cr | 0 | 0 |
| Dec 2023 | 0 | 0 | 0 | 0 | 1 Cr | 0 | 0 |
| Sep 2023 | 0 | 0 | 0 | 0 | 2 Cr | 0 | 0 |
| Yearly | Change To Net income | Dividends Paid | Change To Inventory | Investments | Net Income | Depreciation | Capital Expenditures |
| Mar 2024 | 0 | 0 | 6 Cr | -1 Cr | 4 Cr | 1 Cr | 89 Lac |
| Mar 2023 | 0 | 0 | -2 Cr | 0 Cr | 16 Cr | 2 Cr | 47 Lac |
| Mar 2022 | 0 | 0 | -1 Cr | 10 Cr | 2 Cr | 22 Lac | 49 Lac |
| Mar 2021 | 0 | 0 | -12 Cr | 9 Cr | -7 Cr | 78 Lac | 49 Lac |
| Date | Target 3 | Target 2 | Target 1 | Trading Levels | Target 1 | Target 2 | Target 3 | |
|---|---|---|---|---|---|---|---|---|
| 2025-01-22 | 41.95 | 42.05 | 42.20 | 42.40 |
42.55 |
42.75 | 42.90 | 43.00 |
| Date | Opening price | Closing price | Minimum price | Maximum price |
|---|---|---|---|---|
| 2025-01-15 | 44.8 | 46.37 | 44.8 | 47.48 |
| 2025-01-16 | 45.67 | 48.02 | 45.03 | 48.77 |
| 2025-01-17 | 49.9 | 48.86 | 47.46 | 51.68 |
| 2025-01-20 | 48.85 | 46.91 | 46.22 | 48.85 |
| 2025-01-21 | 47.48 | 46.54 | 46.18 | 48.8 |
Lykis Limited engages in the fast moving consumer goods (FMCG) business in India and internationally. The company provides personal care products including skin care products, such as creams, face wash, body oil, lotion, shower gel, masks, face and body scrub, hair removal cream, petroleum jelly, body butter, talc, intimate wash, petroleum jelly, and hand wash; hair care products comprising shampoo, spray, conditioner, base cream, hair food and relaxer, oil, detox mask, cleansing liquid, hair colour and milk, pomade, and gels; toothpaste; soaps; deodorant, perfume, and body mist; and baby cream, oil, shampoo, talc, wipes, and diaper. It also offers FMCG products, including biscuits and cookies; confectionery, such as candy, lollipops, and toffees; commodity products comprising hot pots, stock pots, utensils, footwear, liquor, and others; and other OTC products. The company provides its products under the Lykis, H&H, Rox, Bonita, Monami, Special, Lykon, Bentol, Stylo, Bon Fami, Calmon, Bon Dejeuner, Mellar, Bom Dia, Blue Fins, Bon Appetit, Senhorita, Polo Star, Leopard, Elephant, Carnoba, Classic, Maria, Spectra, Flite, Bahamas, Sparx, Metro, Cipro, Para, Dextrose and Water for Injection, Davigra, Dermogerme, A-DEM, Candicyl, Rectostop-HC, Nystatine, and Davimov brands. It also exports its products. Lykis Limited was formerly known as Greenline Tea & Exports Limited and changed its name to Lykis Limited in July 2012. The company was incorporated in 1984 and is headquartered in Mumbai, India.
| Open | 47.48 |
| LTP | 46.46 |
| Previous Close | 46.54 |
| Day High | 48.8 |
| Day Low | 46.18 |
| Volume | 5087 |
| Company Name | Price | Change | % Chg | Day High | Day Low | Previous Close | Volume |
|---|---|---|---|---|---|---|---|
| Lloyds Steels Industries Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GMR Infrastructure Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 3i Infotech Limited | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Company MARUTI |
LTP 11984.9 |
Change 101.2 |
Gain 0.85 % |
|
Company HEROMOTOCO |
LTP 4049.65 |
Change 24.85 |
Gain 0.62 % |
|
Company ITC |
LTP 439.7 |
Change 2.15 |
Gain 0.49 % |
|
Company SBIN |
LTP 762.65 |
Change 3.6 |
Gain 0.47 % |
|
Company RELIANCE |
LTP 1279.45 |
Change 5.75 |
Gain 0.45 % |
Motilal Oswal's research report on Dixon TechnologiesDixon Technologies (Dixon) reported better-than-expected revenue and EBITDA, driven by strong performance of the mobile and EMS segment, while PAT stood lower than our estimates on higher depreciation, interest, and minority interest. The company’s revenue/EBITDA jumped 117%/112% YoY for 3QFY25. The mobile and EMS segment continues to benefit ...
Shares of Multi Commodity Exchange of India (MCX) crashed 10 percent on January 21. This comes after brokerage Morgan Stanley issued an 'underweight' call for the stock, stating that the firm's Q3 net profit has fallen below its estimate.At 11:20 am on January 21, MCX shares were trading nearly 11% lower at Rs 5,388 apiece.MCX had released its quarterly results for October-December in the post-mar...
Shares of Mankind Pharma slipped 4 percent to Rs 2,606, snapping its two-day gaining streak on the bourses on January 21 after Macquarie downgraded Mankind Pharma to "Underperform" with a target price of Rs 2,150, reflecting a 7 percent downside from the previous close.The international brokerage said that the domestic formulations business remains weak, driven by slower growth in acute therapies,...
The Q3 earnings season kicked off right in the middle of market chaos—caught between pre-budget buzz, US policy jitters, India’s faltering growth, and sky-high valuations. January, already cursed with weak seasonality, has been a rollercoaster of volatility, leaving investors in a pool of caution.One standout trend this season? Investors are getting seriously choosy. This marks a stark differe...
Sellwin Traders, which reported a 90 percent jump in income for the December quarter, on Sunday said it has signed a pact with UAE-based Secorbit FZCO for developing a blockchain-based tokenization platform for equities, bonds, and real-world assets for USD 3 million (around Rs 26 crore).The platform will be developed for Secorbit to “enable the tokenization of equities, bonds, and real-world as...
Saini_Sahab 2022-09-02 18:30:28
my first target 72 second 96 third one 150 long term 350
Login & Reply Like(0) Dislike(0) Repost Spam